8-K: ALT5 Sigma Reports Strong Q4 and Full-Year 2024 Results, Exceeds 1,000 Customer Milestone

ALT5 Sigma announces record Q4 revenue of $5.4 million and surpasses 1,000 customers, marking a significant milestone in its fintech growth.

Summary

• ALT5 Sigma Corporation reported its Q4 and full-year 2024 financial results.
• The company's Fintech segment achieved a record-breaking Q4 with $5.4 million in revenue.
• ALT5 Sigma's customer base exceeded 1,000 accounts, a historic milestone.
• The company reported a strong annual gross margin of 50.2% for its Fintech segment.
• Adjusted EBITDA for the Fintech segment was an impressive 18.2%.
• The company saw a significant working capital improvement of $4.5 million from Q3 to Q4.
• Ron Pitters has been appointed as the new Chief Operating Officer.
• The Biotech segment (Alyea Therapeutics Corporation) commenced funding in Q4 and is pursuing plans for a future independent listing.
• ALT5 Sigma processed over $2 billion USD in cryptocurrency transactions in 2024.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, strategic leadership appointments, and successful milestones. The tone is optimistic and confident about future growth.

Positives

• Record-breaking Q4 revenue of $5.4 million indicates strong growth.
• Surpassing 1,000 customers demonstrates market acceptance and scalability.
• High gross margin of 50.2% suggests efficient operations and pricing strategy.
• Impressive adjusted EBITDA of 18.2% reflects profitability and financial health.
• Significant working capital improvement of $4.5 million enhances financial flexibility.
• Appointment of Ron Pitters as COO brings experienced leadership to drive growth.
• Successful acquisition of ALT5 Sigma, Inc. expands the company's fintech capabilities.
• The company was honored as the Best Payment Provider at the SiGMA Eurasia Awards 2025.
• ALT5 Sigma processed over $2 billion USD in cryptocurrency transactions in 2024.

Risks

• The forward-looking statements are subject to risks and uncertainties, including international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion.
• The company's periodic reports filed with the SEC detail other potential risks.

Future Outlook

ALT5 Sigma is focused on scaling its operations and delivering exceptional value, leveraging its blockchain technology to reshape the digital asset landscape.

Management Comments

• Peter Tassiopoulos, CEO, stated that the company is firmly positioned for sustained growth with a robust 50.2% gross margin and an 18.2% adjusted EBITDA for the Fintech segment.
• Peter Tassiopoulos, CEO, mentioned that the Fintech segment outpaced ALT5's total pre-acquisition revenue in 2023 despite operating for just two and a half quarters in 2024.
• Peter Tassiopoulos, CEO, expressed excitement about the future and commitment to scaling operations and delivering exceptional value.
• Peter Tassiopoulos, CEO, welcomed Ron Pitters as the new COO and expressed confidence in his ability to scale ALT5 to new heights.
• Peter Tassiopoulos, CEO, stated that Alyea has made some key additions to their team as they ramp up for a planned standalone listing and prepare for the pivotal study on their novel formulation of low-dose naltrexone (LDN).

Industry Context

The announcement highlights ALT5 Sigma's position in the growing fintech and digital asset space, emphasizing its blockchain-powered technologies and payment solutions. The company's focus on cryptocurrency transactions and integration with platforms like Odoo aligns with the increasing adoption of digital currencies in global commerce.

Comparison to Industry Standards

• Comparing ALT5 Sigma's 50.2% gross margin to other fintech companies, firms like Block (formerly Square) often report gross profit margins in the 30-40% range, suggesting ALT5 Sigma is operating efficiently.
• Companies like PayPal and Adyen, which are major players in the payment processing industry, have EBITDA margins that can vary widely, but ALT5 Sigma's 18.2% adjusted EBITDA is competitive.
• The $2 billion in cryptocurrency transactions processed in 2024 places ALT5 Sigma as a significant player in the digital asset transaction space, though smaller than giants like Coinbase or Binance.

Management Changes

Stakeholder Impact

• Shareholders can expect potential value creation from the growth of the Fintech segment and the planned standalone listing of Alyea Therapeutics.
• Customers will benefit from enhanced payment solutions and greater flexibility in trading and cryptocurrency payments.
• Employees may experience growth opportunities as the company scales its operations.

Next Steps

• Alyea Therapeutics Corporation is preparing for a pivotal study on their novel formulation of low-dose naltrexone (LDN).
• Alyea Therapeutics Corporation is planning a standalone listing.
• ALT5 Sigma will continue to focus on leveraging its blockchain technology to reshape the digital asset landscape.

Key Dates

Keywords

Fintech, Blockchain, Cryptocurrency, Digital Assets, Payments, EBITDA, Revenue, ALT5 Sigma, ALTS